Together, these genes form a transcriptionally and post-transcriptionally coordinated network shaped by exosomes and BCR-ABL, highlighting their potential as targets to disrupt microenvironment-mediated resistance in CML. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.